<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Kaczmarczyk JA</submitter><funding>CCR NIH HHS</funding><funding>NCI NIH HHS</funding><pagination>2022-2038</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8487723</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>12(20)</volume><pubmed_abstract>Lung cancer is the leading cause of cancer-related deaths in the USA and worldwide. Yet, about 95% of new drug candidates validated in preclinical phase eventually fail in clinical trials. Such a high attrition rate is attributed mostly to the inability of conventional two-dimensionally (2D) cultured cancer cells to mimic native three-dimensional (3D) growth of malignant cells in human tumors. To ascertain phenotypical differences between these two distinct culture conditions, we carried out a comparative proteomic analysis of a membrane fraction obtained from 3D- and 2D-cultured NSCLC model cell line NCI-H23. This analysis revealed a map of 1,166 (24%) protein species regulated in culture dependent manner, including differential regulation of a subset of cell surface-based CD molecules. W</pubmed_abstract><journal>Oncotarget</journal><pubmed_title>Comparative microsomal proteomics of a model lung cancer cell line NCI-H23 reveals distinct differences between molecular profiles of 3D and 2D cultured cells.</pubmed_title><pmcid>PMC8487723</pmcid><funding_grant_id>HHSN261200800001E</funding_grant_id><funding_grant_id>HHSN261200800001C</funding_grant_id><pubmed_authors>Simona C</pubmed_authors><pubmed_authors>Chan KC</pubmed_authors><pubmed_authors>Roberts RR</pubmed_authors><pubmed_authors>Van Wagoner CM</pubmed_authors><pubmed_authors>Kaczmarczyk JA</pubmed_authors><pubmed_authors>Luke BT</pubmed_authors><pubmed_authors>Felder RA</pubmed_authors><pubmed_authors>Saul RG</pubmed_authors><pubmed_authors>Blonder J</pubmed_authors></additional><is_claimable>false</is_claimable><name>Comparative microsomal proteomics of a model lung cancer cell line NCI-H23 reveals distinct differences between molecular profiles of 3D and 2D cultured cells.</name><description>Lung cancer is the leading cause of cancer-related deaths in the USA and worldwide. Yet, about 95% of new drug candidates validated in preclinical phase eventually fail in clinical trials. Such a high attrition rate is attributed mostly to the inability of conventional two-dimensionally (2D) cultured cancer cells to mimic native three-dimensional (3D) growth of malignant cells in human tumors. To ascertain phenotypical differences between these two distinct culture conditions, we carried out a comparative proteomic analysis of a membrane fraction obtained from 3D- and 2D-cultured NSCLC model cell line NCI-H23. This analysis revealed a map of 1,166 (24%) protein species regulated in culture dependent manner, including differential regulation of a subset of cell surface-based CD molecules. W</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Sep</publication><modification>2026-05-09T01:40:53.984Z</modification><creation>2022-02-11T11:53:33.707Z</creation></dates><accession>S-EPMC8487723</accession><cross_references><pubmed>34611477</pubmed><doi>10.18632/oncotarget.28072</doi></cross_references></HashMap>